Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
129 USD | -0.17% | +1.65% | +18.41% |
04:45pm | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
02:35pm | Redburn Atlantic Adjusts Price Target on Merck to $148 From $142 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.41% | 327B | |
+32.89% | 704B | |
+28.59% | 577B | |
-3.67% | 348B | |
+5.15% | 288B | |
+14.83% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.14% | 147B | |
-7.90% | 145B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck : Acceleron Pharma Shareholder Says Merck & Co.'s Offer Significantly Undervalues Company